Response to Letter to the Editor: "Higher Circulating Adiponectin Concentrations Predict Incident Cancer in Type 2 Diabetes - The Adiponectin Paradox"

J Clin Endocrinol Metab. 2020 Sep 1;105(9):dgaa386. doi: 10.1210/clinem/dgaa386.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adiponectin
  • Diabetes Mellitus, Type 2* / epidemiology
  • Humans
  • Neoplasms* / epidemiology
  • Risk Factors

Substances

  • Adiponectin